RoboInd market brief: Robotic Endoscopy Devices Market is estimated at USD 2.9 billion in 2025. The report cites a CAGR of 9.3% over 2026–2033.
Market snapshot
- USD 2.9 billion in 2025
- USD 3.2 billion in 2026
- USD 6 billion in 2033
Stated compound annual growth rate: 9.3% (2026–2033).
Market overview
The global robotic endoscopy devices market size was valued at USD 2.9 billion in 2025 and is projected to grow from USD 3.2 billion in 2026 to USD 6.0 billion in 2033, at a CAGR of 9.3% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 40.0% in 2025. The increasing prevalence of gastrointestinal diseases, such as colorectal cancer and gastroesophageal reflux disease (GERD), is one of the primary factors fueling the demand for robotic endoscopy devices.
Market drivers and constraints
- Public report growth driver 1: In addition, technological advancements that have led to the development of more efficient and precise devices have contributed to market growth. The adoption of minimally invasive procedures, rather than traditional open surgeries, is a crucial factor shaping the healthcare market. These procedures provide numerous benefits, including reduced pain, a lower risk of infection, shorter hospital stays, and quicker recovery times, making them a preferred option for…
- Public report growth driver 2: Inflammatory bowel disease, which is estimated to affect a large number of the global population across all genders and age groups, is contributing significantly to the demand for robotic endoscopy devices for its treatment. Moreover, the rising prevalence of pancreatic cancer and gastroesophageal reflux diseases is leading patients to prefer surgical methods, resulting in increased demand for these devices and significantly expanding the market.
- Public report growth driver 3: Furthermore, the rise in investments and grants from the government and other organizations is enhancing healthcare providers' focus on adopting robotic endoscopic technologies. The improved diagnostic accuracy and treatment outcomes associated with these technologies are also fueling their demand, thereby contributing to substantial market growth.
Applications and segments
- Public report segmentation list
Competitive landscape
Public report coverage names Asensus Surgical US, Inc. The list reflects participants identified by the source and is not a ranking.
Reading the figures: Values follow the market definition and forecast period stated in the source report. Estimates using different scopes should not be combined without normalization.